Hikma Pharmaceutical | HIK - Interest Expense On Debt


Hikma Pharmaceutical reported $67M in Interest Expense on Debt for its fiscal semester ending in December of 2025.





Interest Expense On Debt Change Date
argenx SE USD 1000K 172K Mar/2026
AstraZeneca USD 340M 144M Jun/2026
Autolus Therapeutics Ltd USD 11.12M 11.71M Mar/2026
Bayer EUR 675M 87M Dec/2025
Fresenius EUR 81M 5M Sep/2025
Genmab DKK 139M 129M Jun/2026
GlaxoSmithKline GBP 121M 46M Jun/2026
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lakefront Biotherapeutics EUR 1.72M 940K Sep/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 137M 33M Jun/2026
Orion EUR 700K 700K Jun/2026
Recordati EUR 22.13M 1.43M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 287M 109M Jun/2026
UCB EUR 49M 29M Dec/2025